These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8711834)
1. [Traditional and future criteria for progression in renal cell carcinoma. Molecular biology and clinical aspects]. Pomer S; Staehler G Urologe A; 1996 May; 35(3):254-62. PubMed ID: 8711834 [TBL] [Abstract][Full Text] [Related]
2. Precancerous lesions in the kidney. Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893 [TBL] [Abstract][Full Text] [Related]
3. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related]
4. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029 [TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764 [TBL] [Abstract][Full Text] [Related]
6. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725 [TBL] [Abstract][Full Text] [Related]
7. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809 [TBL] [Abstract][Full Text] [Related]
8. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951 [TBL] [Abstract][Full Text] [Related]
10. A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma. Lohse CM; Cheville JC Clin Lab Med; 2005 Jun; 25(2):433-64. PubMed ID: 15848745 [TBL] [Abstract][Full Text] [Related]
11. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma. Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis. Gunawan B; Huber W; Holtrup M; von Heydebreck A; Efferth T; Poustka A; Ringert RH; Jakse G; Füzesi L Cancer Res; 2001 Nov; 61(21):7731-8. PubMed ID: 11691785 [TBL] [Abstract][Full Text] [Related]
13. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]
14. Prognostic models and algorithms in renal cell carcinoma. Lane BR; Kattan MW Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615 [TBL] [Abstract][Full Text] [Related]